Acting Assistant Attorney General Matthew R. Galeotti Delivers Remarks at 26th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress

# Acting AAG Highlights Health Care Fraud Enforcement Priorities

Acting Assistant Attorney General Matthew R. Galeotti outlined the Criminal Division's aggressive approach to combating health care fraud during remarks at the 26th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress in Washington, D.C. on October 22, 2025. Galeotti emphasized that prosecuting white-collar crime in the health care sector—including biopharma, medical devices, and insurance—remains a top enforcement priority announced in May.

The Criminal Division's Health Care Fraud Unit has achieved significant results this year. In June, the department announced the largest health care fraud takedown in U.S. history, charging over 300 individuals including nearly 100 medical professionals in schemes involving $14.6 billion in fraudulent claims against Medicare, Medicaid, and other federal health care programs. Additionally, in March, prosecutors secured a 17-year sentence against a pharmacist and obtained $405 million in forfeiture—the largest health care fraud forfeiture in DOJ history.

Galeotti stated the division pursues accountability across all levels, from individual practitioners to corporate executives. The enforcement efforts aim to protect patients from unnecessary procedures and false diagnoses, safeguard taxpayer funds, deter future misconduct, and maintain public confidence in the justice system.